Novo Nordisk Pharma

About Novo Nordisk Pharma

Novo Nordisk Pharma Gulf FZE is a subsidiary of Novo Nordisk A/S, a Danish pharmaceutical company. The company is headquartered in Dubai, United Arab Emirates, and it is responsible for the commercialization of Novo Nordisk's products in the Middle East and North Africa region. Novo Nordisk Pharma Gulf FZE was founded in 1993, and it currently employs over 1,000 people in the MENA region. The company's products are used to treat a variety of chronic diseases, including diabetes, obesity, growth disorders, and hemophilia. Novo Nordisk Pharma Gulf FZE is committed to providing patients in the MENA region with access to high-quality healthcare. The company works closely with healthcare professionals to ensure that patients have the information and support they need to manage their chronic diseases.